Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics.
| Title | Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics. |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Mikhailidis, D. P., & Athyros V. G. |
| Journal | Nat Rev Cardiol |
| Volume | 11 |
| Issue | 2 |
| Pagination | 72-4 |
| Date Published | 2014 Feb |
| ISSN | 1759-5010 |
| Keywords | Dyslipidemias, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Practice Guidelines as Topic, Retrospective Studies |
| Abstract | The new ACC/AHA guidelines on treatment of blood cholesterol focus on intensity of statin therapy rather than target levels of lipids. Early studies show substantial reductions in LDL-cholesterol level with antibodies against PCSK9. MicroRNA silencing and gene-repair techniques to treat dyslipidaemia are promising strategies under development. |
| DOI | 10.1038/nrcardio.2013.209 |
| Alternate Journal | Nat Rev Cardiol |
| PubMed ID | 24366071 |
